Increased mitochondrial fusion allows the survival of older animals in diverse C. elegans longevity pathways


Mitochondria are dynamic organelles that undergo fusion and fission events. Mitochondrial dynamics are required for mitochondrial viability and for responses to changes in bioenergetic status. Here we describe an insulin-signaling and SCFLIN-23-regulated pathway that controls mitochondrial fusion in Caenorhabditis elegans by repressing the expression of the mitochondrial proteases SPG-7 and PPGN-1. This pathway is required for mitochondrial fusion in response to physical exertion, and for the associated extension in lifespan. We show that diverse longevity pathways exhibit increased levels of elongated mitochondria. The increased mitochondrial fusion is essential for longevity in the diverse longevity pathways, as inhibiting mitochondrial fusion reduces their lifespans to wild-type levels. Our results suggest that increased mitochondrial fusion is not a major driver of longevity, but rather is essential to allow the survival of older animals beyond their normal lifespan in diverse longevity pathways.


Mitochondria play diverse roles in signaling, physiology, and metabolism1. Mitochondrial dynamics regulate the morphology, number, and function of mitochondria to allow adaptation to cellular needs1. Mitochondrial fission is required for: mitophagy; the mitotic segregation of mitochondria to daughter cells; and the distribution of mitochondria to subcellular locations, such as neuronal axons2. Mitochondrial fusion is required for maintaining mitochondrial membrane potential and respiratory capacity, and to protect against apoptosis in mammalian cells3.

Cells adjust mitochondrial morphologies to coordinate between the cellular demand for energy and the availability of resources3. Elongated morphology is associated with increased efficiency of ATP production and reduced generation of reactive oxygen species (ROS), while fragmented morphology is linked to reduced ATP production and mitochondrial uncoupling.

Mitochondrial fusion and fission events are tightly regulated and require the activity of evolutionarily conserved GTPases4. Mitochondrial fission in yeast, invertebrates, and mammals requires the dynamin-related protein DNML1 (Dnm1 in budding yeast and DRP-1 in C. elegans). Mitochondrial fusion requires mitofusins for outer membrane fusion (MFN1 and MFN2 in mammals, Fzo1 in budding yeast, and FZO-1 in C. elegans), and inner membrane fusion (OPA1 in mammals, Mgm1 in budding yeast, and EAT-3 in C. elegans)4,5,6. In mammalian cells, overexpression of the outer membrane fusion proteins MFN1 and MFN2 can lead to either clustering of spherical mitochondria7,8,9 or elongated mitochondria9, 10. It is likely that the different outcomes result from differences in the level of expression, as it was shown that modest overexpression of the inner membrane fusion protein OPA1 induces mitochondrial fusion, while higher levels of expression induce fragmentation11. In C. elegans, the overexpression of either the outer membrane mitofusin FZO-1 or the inner membrane fusion EAT-3 was reported to induce mitochondrial fragmentation6; however, in light of the mammalian results, the failure to generate elongated mitochondria could have resulted from excessive expression levels.

Mitochondrial dysfunction, impaired energy homeostasis, and increased production of ROS are associated with aging in both invertebrates and vertebrates12. In large-scale C. elegans RNA interference (RNAi) screens for genes regulating lifespan, one of the largest classes of genes were those encoding mitochondrial proteins affecting the electron transport chain (ETC)13, the RNAi depletion of which can either shorten or extend lifespan. Lifespan extension in response to ETC impairment occurs, at least in part, from the activation of the mitochondrial unfolded protein response (UPRmt)14. In this study, we present evidence that increased mitochondrial elongation, which occurs independently of UPRmt, allows the survival of older animals in diverse longevity pathways.

Insulin/IGF-1 signaling (IIS) is an evolutionarily conserved pathway that controls lifespan15. In C. elegans, IIS reduces lifespan predominantly by inhibiting the activity of the FOXO transcription factor DAF-16 via inhibitory phosphorylation that blocks its nuclear localization. In the absence of IIS activity, DAF-16 enters the nucleus and regulates gene expression to extend lifespan.

In this study, we describe a pathway for the control of mitochondrial fusion in C. elegans that is regulated by IIS and a cullin-RING ubiquitin ligase (CRL). CRLs are multisubunit ubiquitin ligases (E3s) that ubiquitylate substrate proteins to induce proteasome-mediated degradation or post-translational regulation16, 17. CRLs include a cullin protein as a scaffold, a RING finger protein, which binds the ubiquitin-conjugating enzyme, a substrate receptor that binds the substrate, and (generally) an adaptor that links the substrate receptor to the core complex. Substrate receptors are variable components, and core CRL complexes function with multiple substrate receptors. The binding of a different substrate receptor to the core CRL complex changes the substrates that are targeted and the cellular function. The most widely studied class of CRLs contains the cullin CUL1 and is designated SCF for its core components: the Skp1 adaptor; CUL1; and F-box protein substrate receptors.

The CAND1 protein functions as an exchange factor for CRL substrate receptors18,19,20. CAND1 affects the steady-state levels of different substrate receptors with the core CRL components18,19,20. In diverse organisms, the loss of CAND1 selectively affects a subset of CRLs, suggesting that certain substrate receptors are particularly reliant on CAND1 activity16, 17.

Here, we describe a C. elegans mitochondrial fusion pathway that is regulated by CAND-1, the E3 SCFLIN-23, and IIS. We show that this pathway is responsible for an increase in elongated mitochondria in response to physical exercise. Additionally, we show that increased levels of elongated mitochondria are associated with diverse lifespan extension pathways, and that the increase in mitochondrial elongation is required to allow the survival of older animals during extended lifespans.


The mitochondrial protease spg-7 is a cand-1 suppressor

Inactivation of C. elegans cand-1 results in developmental and morphological defects, including impenetrant embryonic and larval arrest, developmental delays, altered cell divisions, and morphological defects21. To identify CAND-1 molecular pathways, we isolated a genetic suppressor mutation, ek25, that suppresses multiple cand-1(tm1683) loss-of-function phenotypes (Supplementary Table 1). ek25 was identified as an insertion mutation in an intron of the spg-7 gene and the 3′ untranslated repeat (UTR) of the Y47G6A.15 gene (Supplementary Figs. 1 and 2). Y47G6A.15 is not conserved even in closely related Caenorhabditis species. spg-7 is the ortholog of the mammalian mitochondrial m-AAA protease AFG3L2 22. RNAi depletion of spg-7 in cand-1 mutants enhanced cand-1 mutant phenotypes, and abrogated suppression in cand-1; spg-7(ek25) animals (Supplementary Table 1). In contrast, RNAi inactivation of Y47G6A.15 had no obvious effects (Supplementary Table 1).

CAND-1 positively regulates spg-7 mRNA levels. cand-1 mutants have lower levels of spg-7 mRNA than wild type, and the spg-7(ek25) mutant allele rescues the decrease in spg-7 expression in cand-1 mutants (Fig. 1a and Supplementary Fig. 3). These results suggest that spg-7(ek25) acts as a gain-of-function mutation that suppresses cand-1 mutant phenotypes by restoring spg-7 expression.

Fig. 1

CAND-1/SCFLIN-23 regulates mitochondrial shape via spg-7 and ppgn-1. a Real-time PCR quantification of spg-7 mRNA levels in adults of the indicated genotypes, presented in arbitrary units (a.u.) normalized to control rpl-19 (ribosomal protein L19) mRNA. Error bars denote s.e.m. from four biological replicates, each with at least two technical replicates. P values were determined by Student’s t-test. b Images of tubular, elongated, and fragmented mitochondria visualized by mitochondria-targeted GFP expressed in body-wall muscle cells. Scale bar, 10 µm. c The percentages of muscle cells with tubular, elongated, and fragmented mitochondria for the indicated genotypes and RNAi treatments. All animals were fed either gene-specific RNAi or control RNAi so that the feeding conditions were matched. P values were determined by χ 2-test. Sample size (n) of muscle cells from left to right are: 729; 126; 210; 124, 210; 201; 234; 274; 209; 297; 318; 457. Mitochondrial morphology was scored blinded. d Real-time PCR quantification of ppgn-1 mRNA levels normalized to control rpl-19 mRNA in adults of the indicated genotypes. Error bars denote s.e.m. from three biological replicates, each with at least two technical replicates. P values determined by Student’s t-test. For all panels, asterisks above bars denote P value comparisons to wild-type/controls; asterisks above lines denote comparisons under the lines: *P < 0.05; **P < 0.01; ***P < 0.001; ns = not significant

CAND-1 and LIN-23 regulate mitochondrial morphology

Since the spg-7(ek25) suppressor regulates the expression of a mitochondrial m-AAA protease, we wanted to determine whether cand-1 mutants have a mitochondrial phenotype. To characterize mitochondrial morphology, we used a transgenic strain expressing mitochondria-targeted green fluorescent protein (GFP) in muscle cells23. Mitochondrial morphology was scored blinded, and the scoring correlates with a quantitative assessment of mitochondrial area (Supplementary Fig. 4). The majority of wild-type hermaphrodite body-wall muscle cells have longitudinally arrayed tubular mitochondria (Fig. 1b, c). Smaller percentages of muscle cells exhibit elongated mitochondria in an interconnected mesh-like network, or fragmented mitochondria (Fig. 1b, c). Inactivation of cand-1 significantly increases the percentage of cells exhibiting elongated mitochondria; moreover, this phenotype is rescued by the spg-7(ek25) suppressor mutation in cand-1, spg-7(ek25) animals (Fig. 1c and Supplementary Fig. 5). Inactivation of the COP9/Signalosome component CSN-3, which, like CAND-1, is required for CRL function16, 17, also increased the proportion of elongated mitochondria (Fig. 1c and Supplementary Fig. 5). This suggests that the increased mitochondrial elongation phenotype in cand-1 mutants arises from loss of CRL activity. The E3 SCFLIN-23, which contains the substrate receptor LIN-23, is particularly reliant on CAND-1 for activity21. We found that inactivation of lin-23 similarly reduces spg-7 expression and has increased levels of elongated mitochondria (Fig. 1a, c and Supplementary Fig. 5).

CAND-1 and SCFLIN-23 regulate mitochondria through DAF-16

spg-7(ad2249) loss-of-function and spg-7(tm2312) deletion (∆) mutants exhibit mitochondrial elongation, but the proportion of mitochondria with elongated morphology is not as large as that observed in cand-1(RNAi) or lin-23(RNAi) animals (Fig. 1c and Supplementary Fig. 5). Mammalian m-AAA proteases form hexameric complexes in the inner mitochondrial membrane that exist as hetero-oligomeric complexes of AFG3L2 and SPG7, or homo-oligomeric complexes of AFG3L224. We considered whether the partial mitochondrial fusion phenotype of spg-7/AFG3L32 mutants could arise from functional redundancy between SPG-7 and PPGN-1, the C. elegans ortholog of mammalian SPG7.

We found that inactivation of ppgn-1 alone increased mitochondrial fusion, while inactivating both ppgn-1 and spg-7 further increased the level of elongated mitochondria, implying that both m-AAA proteases negatively regulate mitochondrial elongation (Fig. 1c). CAND-1 and LIN-23 also promote ppgn-1 expression (Fig. 1d), suggesting that the increase in mitochondrial elongation in cand-1 and lin-23 mutants arises from the failure to adequately express both spg-7 and ppgn-1.

To determine how the spg-7(ek25) mutation increases spg-7 mRNA levels, we looked for transcription factor-binding sites that are affected by the spg-7(ek25) mutation. The spg-7(ek25) mutation disrupts a consensus DAF-16-binding element (DBE)25 within a region confirmed for DAF-16 binding by chromatin immunoprecipitation sequencing (ChIP-seq)26 (Supplementary Fig. 2). DAF-16 was also shown to bind to the ppgn-1 regulatory region26. A meta-analysis of DAF-16-responsive genes suggests that DAF-16 can repress gene expression through DBE sites (Methods). daf-16(mu86) deletion mutants have elevated levels of spg-7 and ppgn-1 mRNA, suggesting that DAF-16 is a transcriptional repressor of both spg-7 and ppgn-1 (Fig. 1a, d). Unexpectedly, the reduction of ppgn-1 mRNA levels observed in cand-1 mutants was also rescued by the spg-7(ek25) suppressor allele. The mechanism for this effect is not known but could involve feedback loop(s) or the co-regulation of spg-7 and ppgn-1 expression.

We wanted to determine whether CAND-1 and SCFLIN-23 promote spg-7 and ppgn-1 expression by inhibiting DAF-16 activity. One of the primary mechanisms to control DAF-16 activity is by regulating its nuclear localization15. We observed that inactivation of cand-1, cul-1, and lin-23 significantly increased DAF-16::GFP nuclear localization, suggesting that CAND-1 and SCFLIN-23 normally act to inhibit DAF-16 nuclear localization (Fig. 2a, b). To determine whether the CAND-1-mediated inhibition of mitochondrial fusion is dependent on DAF-16 activity, we combined daf-16 and cand-1 loss-of-function mutations. The addition of the daf-16 mutation rescued the cand-1-elongated mitochondria phenotype, suggesting that CAND-1 inhibits mitochondrial elongation by negatively regulating DAF-16 activity (Fig. 1c).

Fig. 2

CAND-1/SCFLIN-23 activates AKT-1 to inhibit DAF-16 and reduce EAT-3 levels. a DAF-16::GFP nuclear localization in body-wall muscle cells for animals with the indicated RNAi treatments. White arrows indicate nuclei in the control RNAi image. Scale bar, 10 µm. b Quantification of the mean level of nuclear and cytoplasmic DAF-16::GFP intensity in body-wall muscle cells. Error bars denote s.e.m. P values were determined by Student’s t-test. Sample size (n) of body-wall muscle cells from left to right are: 44; 61; 102; 87. c Western blot with anti-GFP of AKT-1::GFP from whole-animal lysate of L4/young-adult-stage animals treated with the indicated RNAi showing the altered mobility of AKT-1::GFP on SDS-PAGE; anti-histone H4 staining is used as a loading control. Similar results were obtained in two to five biological replicates. d Western blot showing staining for an antibody that recognizes AKT phospho-substrates in animals expressing AKT-1::GFP and subjected to the indicated RNAi treatments. Significant decreases in AKT phospho-substrates were observed for cand-1, cul-1, and lin-23 RNAi conditions in three to five biological replicates, with pdk-1 RNAi shown as a control that is known to reduce AKT-1 activity. The identities of the AKT-1 phospho-substrate proteins observed in the western blot are not known. e Graph showing the levels of AKT phospho-substrate signal relative to control protein bands (anti-tubulin or anti-histone H4) for three to five biological replicates. The control RNAi is set to 100 in arbitrary units. Error bars denote s.e.m. P values were determined by Student’s t-test. f Western blot showing EAT-3 protein levels for the indicated genotypes and RNAi treatments. The expected molecular weights of the L-isoform and S-isoform of EAT-3 are 110.1 and 85.5–86.4 kDa, respectively. g Quantification of EAT-3 levels normalized to α-tubulin. Error bars denote s.e.m. from two to four biological replicates. For all panels, asterisks above bars denote P value comparisons to wild type/controls; asterisks above lines denote comparisons under the lines: *P < 0.05; **P < 0.01; ***P < 0.001; ns = not significant

To determine how SCFLIN-23 inhibits DAF-16 nuclear localization, we analyzed the kinase AKT-1, which phosphorylates DAF-16 to prevent its nuclear localization15, 27. Inactivating cand-1 or the SCFLIN-23 components cul-1 or lin-23 leads to the accumulation of a faster-migrating form of AKT-1::GFP without affecting its overall levels (Fig. 2c and Supplementary Fig. 6). AKT-1 is activated by PDK-1 phosphorylation15, 27. RNAi depletion of pdk-1, or the inhibition of the IIS pathway upstream of PDK-1 and AKT-1, results in the accumulation of a faster-migrating form of AKT-1::GFP that is consistent with the unphosphorylated, inactive form (Fig. 2c)28. pdk-1 RNAi does not produce a further shift in the migration of AKT-1::GFP when combined with lin-23 RNAi (Fig. 2c). This suggests that the lower molecular weight form of AKT-1::GFP in lin-23(RNAi) animals reflects the loss of PDK-1-dependent activating phosphorylation.

To further analyze the activity of AKT-1 in cand-1(RNAi), cul-1(RNAi), lin-23(RNAi), and pdk-1(RNAi) animals, we probed whole-animal lysate with a phospho-antibody that detects AKT-phosphorylated substrates. The level of the AKT phospho-epitope was significantly reduced in cand-1, cul-1, lin-23, and pdk-1 RNAi depletions (Fig. 2d, e). The relatively higher AKT phospho-substrate levels in the cand-1(RNAi) animals relative to cul-1, lin-23, or pdk-1 RNAi treatments correlated with the reduced effectiveness of cand-1 RNAi in shifting AKT-1 to the lower molecular weight form in that experiment (Fig. 2c). These results suggest that SCFLIN-23 increases AKT-1 activity by promoting its activating phosphorylation.

SPG-7 and PPGN-1 regulate mitochondrial fusion protein EAT-3

In yeast and mammals, the inner mitochondrial fusion protein, Mgm1 or OPA1, respectively, is cleaved into long (L) and short (S) isoforms, both of which are required for mitochondrial fusion29, 30. In mammals, there are two cleavage sites, S1 and S2. S1 is cleaved by the protease OMA1, and S2 is cleaved by the protease YME1L129. C. elegans lacks an OMA1 homolog, and the corresponding S1 cleavage site is not conserved in EAT-3/OPA1. In contrast, C. elegans has a YME1L1 ortholog, ymel-1, and its target S2 site is conserved in EAT-3. The expected sizes of EAT-3 are consistent with an L-isoform (after removal of the mitochondrial targeting sequence) and an S-isoform cleaved at the conserved S2 site (Fig. 2f).

Mammalian m-AAA components AFG3L2 and SPG7 can cleave OPA1 when overexpressed or expressed ectopically in yeast31, 32. We tested whether inactivating C. elegans spg-7 and ppgn-1 affects EAT-3 levels. Co-inactivation of spg-7 and ppgn-1 significantly increased the overall level of EAT-3, indicating that both m-AAA proteases negatively regulate EAT-3 levels (Fig. 2f, g). cand-1 mutants, which have reduced expression of spg-7 and ppgn-1, have higher levels of EAT-3 protein compared to wild type (Fig. 2f, g). Significantly, the cand-1; spg-7(ek25) strain, which restores expression of spg-7 and ppgn-1 mRNA, does not have elevated EAT-3 levels (Fig. 2f, g). The levels of eat-3 mRNA remain unchanged in the above conditions, indicating that the negative regulation of EAT-3 protein is post transcriptional (Supplementary Fig. 7). It is not known whether the negative regulation of EAT-3 is direct or indirect. EAT-3 appears to function downstream of CAND-1, LIN-23, SPG-7, and PPGN-1, as the eat-3(RNAi) mitochondrial fragmentation phenotype is epistatic to the mitochondrial fusion associated with inactivation of these genes (Fig. 3a, b).

Fig. 3

Mitochondrial morphology in C. elegans body-wall muscles. a, b The percentages of muscle cells with predominantly tubular, elongated, or fragmented mitochondria in adult hermaphrodites of the indicated RNAi treatments visualized by mitochondria-targeted GFP expressed in body-wall muscle cells. P values were determined by χ 2-test. Sample size (n) of muscle cells from left to right are: a 119, 128, 152, 198, 173; and b 151, 111, 173, 125, 136. Mitochondrial morphology was scored blinded. For all panels, asterisks above bars denote P value comparisons to wild type/controls; asterisks above lines denote comparisons under the lines: ***P < 0.001; ns = not significant

The levels of FZO-1::GFP (outer mitochondrial membrane fusion protein) and DRP-1::GFP (inner mitochondrial fission protein) were not affected by inactivation of the mitochondrial fusion pathway genes (Supplementary Fig. 8a, b). We also did not observe a major change in the levels of mitochondria-targeted GFP upon RNAi depletions of the mitochondrial fusion pathway genes (Supplementary Fig. 8c). This suggests that the mitochondrial fusion pathway does not significantly affect the level of mitophagy, as changes in mitophagy affect the level of mitochondria-targeted GFP33.

Our data support the model shown in Fig. 4, in which CAND-1 activates SCFLIN-23, and SCFLIN-23 activates AKT-1, thereby reducing DAF-16-mediated transcriptional repression of spg-7 and ppgn-1. SPG-7 and PPGN-1 inhibit mitochondrial fusion, at least in part, by negatively regulating the level of EAT-3.

Fig. 4

Model for regulation of mitochondrial fusion. a Proposed linear pathway for CAND-1 and SCFLIN-23 regulation of mitochondrial fusion; see text for description. b, c Schematic of the proposed intracellular pathway regulating mitochondrial fusion and lifespan extension in the presence b or absence c of CAND-1

Regulation of mitochondrial fusion in physical exertion

Acute physical exertion in mice induces mitochondrial fusion in skeletal muscle cells34, presumably to increase the efficiency of ATP production3. We wanted to determine whether physical exertion similarly increases mitochondrial fusion in C. elegans, and whether the fusion is DAF-16-dependent. To induce physical exertion, we utilized swimming behavior. Animals were kept in a state of constant swimming by gently rocking them in M9 buffer solution that contained OP50 bacteria. Swimming, which manifests as an intense thrashing motion (Supplementary Movies 1 and 2), appears to be vigorous exercise based on the observation that ATP levels decrease during swimming (Fig. 5a). Wild-type animals and daf-16(mu86) mutants expressing mitochondria-targeted GFP swam vigorously at an equivalent swimming rate (Fig. 5b and Supplementary Movies 13). Wild-type animals showed an increase in elongated mitochondria that reached an elevated plateau at 60 min that persisted through the remainder of the 5-h test period (Fig. 5c and Supplementary Fig. 9a). Significantly, daf-16 mutants did not exhibit increased levels of elongated mitochondria, implying that DAF-16 is required for this physiological response (Fig. 5c and Supplementary Fig. 9b). Consistently, the nuclear localization of DAF-16::GFP increased in response to swimming in wild-type animals (Fig. 5d and Supplementary Fig. 10). Notably, cand-1; spg-7(ek25) mutants, which have stabilized spg-7 and ppgn-1 expression, exhibited a lack of mitochondrial fusion in response to physical exertion despite a slightly faster swim rate (Fig. 5b, c and Supplementary Fig. 9c). Similarly, we did not observe an increase in mitochondrial fusion in spg-7(ek25) mutants, which also swam at a rate equivalent to wild-type animals (Supplementary Fig. 11). This suggests that the DAF-16-mediated inhibition of spg-7 and ppgn-1 regulates mitochondrial dynamics in response to physical exertion.

Fig. 5

DAF-16 is required for physical exertion-induced mitochondrial fusion. a ATP levels decrease during swimming. Graph of ATP levels (normalized to whole-animal protein levels) at the indicated times of continuous swimming. Error bars denote s.e.m. from two biological replicates, each with three technical replicates. P values were determined by Student’s t-test. b Average swim strokes per minute of 12 animals each for the indicated genotypes upon induction of swimming behavior. Error bars denote s.e.m. P values determined by Student’s t-test. c The percentages of muscle cells with elongated mitochondria in wild type, daf-16(mu86), and cand-1(tm1683); spg-7(ek25) animals for the indicated times post induction of swimming behavior. Full distributions of mitochondrial morphology and sample size (n) are shown in Supplementary Fig. 9. d DAF-16::GFP nuclear localization in body-wall muscle cells for animals at 0 and 300 min post induction of swimming behavior. White arrows indicate nuclei in the 0 min image. Scale bar, 10 µm. For all panels, asterisks above bars denote P value comparisons to wild type/controls; asterisks above lines denote comparisons under the lines: *P < 0.05; **P < 0.01; ***P < 0.001; ns = not significant

Mitochondrial fusion is required for IIS lifespan extension

DAF-16 is required for the extended lifespan of IIS pathway mutants27. Because CAND-1 and SCFLIN-23 inhibit DAF-16 nuclear localization, we hypothesized that inactivation of these regulators would extend lifespan. As expected, RNAi depletion of cand-1 and lin-23 (begun in the late-L4 larval stage to ensure normal larval development) extended lifespan (Fig. 6a; see Supplementary Table 2 for statistics on lifespan data). Interestingly, the cand-1; spg-7(ek25) strain, which rescues the cand-1 increase in elongated mitochondria, had normal lifespan, suggesting that the extended lifespan of cand-1 mutants requires increased levels of elongated mitochondria (Fig. 6b).

Fig. 6

Increased mitochondrial elongation extends lifespans. ae Survival curves for adults of the indicated RNAi treatments. The wild-type survival curves for ac were analyzed at the same time and are shown in each panel for comparison. RNAi depletions of lin-23 a, cand-1 a, ppgn-1 c, and spg-7 + ppgn-1 d significantly increased mean lifespan. b cand-1 mutants and spg-7(tm2312) mutants d had increased the mean lifespan relative to wild type, while cand-1; spg-7(ek25) c animals had lifespan comparable to wild type. e, f eat-3 RNAi e and fzo-1 RNAi f depletions significantly decreased the mean lifespan of daf-2(e1370) mutants. All lifespan experiments were performed with four biological replicates. See Supplementary Table 2 for statistics. g The percentages of muscle cells with predominantly tubular, elongated, or fragmented mitochondria in adult hermaphrodites of the indicated genotypes/RNAi treatments visualized by mitochondria-targeted GFP expression in body-wall muscle cells. P values were determined by χ 2-test. Sample size (n) of muscle cells from left to right are: 278; 102; 179; 207; 136; 218. Mitochondrial morphology was scored blinded. The wild-type control from Fig. 1c was analyzed at the same time and is shown here for comparison. Asterisks above bars denote P value comparisons to wild type/control; asterisks above lines denote comparisons under the lines: *P < 0.05; **P < 0.01; ***P < 0.001; ns = not significant

Notably, we observed that increasing mitochondrial fusion independently of DAF-16 produces a modest extension of lifespan. ppgn-1(RNAi), spg-7(∆), and spg-7 + ppgn-1 double RNAi animals, all of which exhibit increases in elongated mitochondria (Fig. 1c), had extended lifespan (Fig. 6c, d). In contrast to spg-7(∆) mutants, spg-7(RNAi) animals do not exhibit increased levels of elongated mitochondria (Fig. 3b), potentially because of the impenetrant effects of RNAi, and consistently had normal lifespan (Fig. 6c).

The mitochondrial fusion pathway includes activating AKT-1 to repress the DAF-16 transcription factor. The IIS pathway has the same downstream pathway, and so mutation of the IIS receptor DAF-2 would also be expected to activate DAF-16-mediated repression of spg-7 and ppgn-1 to activate mitochondrial fusion. Consistent with this, daf-2 mutants exhibit increased levels of elongated mitochondria (Fig. 6g). To determine the extent to which increased levels of elongated mitochondria contribute to the extended daf-2 mutant lifespan, we inactivated the mitochondrial fusion gene eat-3 in daf-2 mutants. Strikingly, eat-3 RNAi reduced the extended lifespan of daf-2 mutants to wild-type levels (Fig. 6e). To test an alternate method to reduce elongated mitochondria in daf-2 mutants, we RNAi-depleted the outer membrane fusion protein FZO-1; moreover, this also significantly reduced the extended lifespan of daf-2 mutants (Fig. 6f). These results suggest that increased levels of mitochondrial elongation are required for lifespan extension in daf-2 mutants.

Elongated mitochondria are known to produce ATP more efficiently3. We analyzed ATP levels in several key mutants, and found a correlation between increased levels of elongated mitochondria and increased ATP/protein ratios (Supplementary Fig. 12). The daf-2 mutant is known to have significantly increased ATP levels35, and had the highest ATP levels in our assay. Additionally, statistically significant increases in ATP levels were observed in lin-23(RNAi), cand-1(lf), and ppgn-1(RNAi) animals, all of which have increased levels of elongated mitochondria. spg-7(RNAi) animals, which do not exhibit increased levels of elongated mitochondria (Fig. 3b), did not have significantly increased ATP levels. The observation that cand-1(lf); spg-7(ek25) mutants had significantly lower ATP levels than cand-1(lf) mutants suggests that a significant portion of the increase in ATP levels in cand-1(lf) mutants can be attributed to the reduction of spg-7 expression. That ATP levels in cand-1(lf); spg-7(ek25) remained higher than in wild type may reflect the impact of the loss of CAND-1 on other CRL-regulated processes.

Physical exertion extends lifespan

We observed that during swimming, DAF-16 nuclear localization increases, which is associated with lifespan extension. We wanted to determine whether exercise would increase the median lifespan. Making animals swim initially for 30 min per day, followed by consecutive reductions in swim time of 1 min per day, produced significant lifespan extension. However, this swimming regimen (A) caused a rapid drop-off in the viability of older animals (Fig. 7a, see Supplementary Table 3 for statistics). To limit the stress on older animals, we tested two different swimming regimens (B and C) that further reduced the extent of swimming as the animals aged: an initial rate of 30 min swimming/day was tapered via arbitrary reductions (regimen B, Fig. 7 legend), or reductions of two min per day (regimen C). These age-moderated swim regimens produced further lifespan extensions relative to regimen A (Fig. 7b).

Fig. 7

Exercise extends lifespan that is dependent on the mitochondrial fusion pathway. ad Survival curves for adults that were kept continuously on agar plates or removed from the plates for brief periods for the described swim regimens. a Comparison of wild-type kept on agar plates continuously or subject to swim regimen A (30 min of swimming per day). b Test of swim regimens B and C. Swim regimen B was the following swimming times per day on the listed days: 30 min on days 1–5; 25 min on days 6 and 7; 20 min on days 8 and 9; 15 min on day 10; 10 min on day 11; and 5 min on day 12. Swim regimen C was 30 min of swimming on day 1, followed by a reduction in swim time of 2 min per day on subsequent days. c, d Test of swim regimen C with wild type, cand-1(tm1683); spg-7(ek25) c, or daf-16(mu86) d. The wild-type control and wild-type swim regimen C survival curves were analyzed at the same time and are shown in c, d for comparison. All swimming regimens significantly increased the mean lifespan of wild type ad. Swim regimen C did not increase the mean lifespan of cand-1(tm1683); spg-7(ek25) c or daf-16(mu86) mutants d relative to the control, non-swimming condition. All lifespan experiments were performed with four biological replicates. See Supplementary Table 3 for statistics

Notably, cand-1; spg-7(ek25) and daf-16 mutants, which failed to exhibit increased mitochondrial fusion in response to swimming, did not exhibit lifespan extension in response to swimming (Fig. 7c, d). This suggests that the induction of mitochondrial fusion during exercise contributes to the observed lifespan extension.

Because of how the swim experiments were carried out, the lifespans of the control animals are not directly comparable to the lifespans of control animals in other (non-swim) experiments. Control animals in the swim experiments had shorter lifespans than the control animals in non-swim experiments. Presumably, this difference arose because all animals in the swim experiments (including controls) were kept at room temperature during the swim periods (rather than the lower temperature of 20 °C) and were transferred daily to new plates. Notably, the swim regimens B and C produced a significant extension of lifespan even when compared to control animals from the non-swim lifespan experiments (Supplementary Table 3).

Mitochondrial fusion is broadly required for longevity

To determine whether mitochondrial fusion is more broadly correlated with longevity, we analyzed the mitochondrial morphologies of animals that exhibit longevity from five distinct mechanisms: age-1(RNAi) and pdk-1(RNAi) animals have extended lifespan from loss of IIS15; eat-1(RNAi) and eat-6(RNAi) animals have extended lifespan linked to caloric/dietary restriction36; clk-1(RNAi) extends lifespan because of mitochondrial ETC dysfunction; glp-1(RNAi) extends lifespan as a result of the loss of the germline37; and vhl-1, the von Hippel Lindau tumor suppressor ortholog, mutants/RNAi animals have lifespan extension due to deregulation of the hypoxia transcriptional program38.

We analyzed the distribution of mitochondrial morphologies in the seven long-lived strains. Strikingly, six of the seven long-lived mutants/RNAi animals had increased levels of elongated mitochondria, with vhl-1(RNAi) animals the lone exception, with predominantly tubular mitochondria (Fig. 8a, b and Supplementary Fig. 5). Caloric restricted mutants, such as eat-6, have lifespan extension independent of DAF-1636. We found that the increase in elongated mitochondria in eat-6 mutants was not affected by daf-16 RNAi, suggesting that mitochondrial morphology in these mutants is regulated through a DAF-16-independent pathway (Fig. 8a). In other organisms, nutrient limitation increases mitochondrial fusion3, and it is possible that a similar mechanism operates in C. elegans.

Fig. 8

Diverse life extension pathways have increased levels of elongated mitochondria. a, b The percentages of body-wall muscle cells with tubular, elongated, and fragmented mitochondria in the indicated genotypes, overexpression (oe), and RNAi treatments. P values were determined by χ 2-test. Sample size (n) of muscle cells from left to right are: a 254, 239, 301, 331, 103, 110, 303, 270, 141, 148; and b 148, 181, 120, 121, 98, 114, 153, 122, 260, 264, 143. For all panels, asterisks above bars denote P value comparisons to wild-type/control; asterisks above lines denote comparisons under the lines: *P < 0.05; **P < 0.01; ***P < 0.001; ns = not significant

Strikingly, the increase in elongated mitochondria in these diverse mutants is essential for their longevity. RNAi depletion of the mitochondrial fusion gene eat-3 abolished the extended lifespans of diverse longevity mutants/RNAi: glp-1(e2141ts); eat-2(ad1116) and eat-6(ad467); and clk-1(RNAi) (Fig. 9a–d). Significantly, eat-3 RNAi depletion in a wild-type background or in vhl-1(ok161) mutants, neither of which have significantly elevated elongated mitochondria, did not affect their lifespans (Fig. 9e). This suggests that eat-3 RNAi does not have a negative impact on lifespan directly, but rather acts indirectly by reducing the beneficial effects of increased levels of elongated mitochondria.

Fig. 9

Mitochondrial elongation is required for longevity in diverse mutants. ai Survival curves for adults of the indicated genotypes, overexpressions (oe), and RNAi treatments. The wild-type and eat-3(RNAi) survival curves are shown in graphs for comparison. eat-3 RNAi significantly reduced the extended lifespans relative of all tested genotypes, overexpression, and RNAi treatments except for vhl-1 mutants and wild-type control e. All lifespan experiments were performed with four biological replicates. See Supplementary Table 2 for statistics

Elongated mitochondria have decreased production of ROS3. We measured mitochondrial ROS levels using the dye MitoSOX Red39 in daf-2, glp-1, and eat-6 mutants, all of which have elevated levels of elongated mitochondria. Each of these long-lived mutants had reduced ROS levels, and ROS levels increased significantly upon treatment with eat-3 RNAi to block mitochondrial fusion (Supplementary Fig. 13 and Supplementary Table 4). This suggests that increased levels of elongated mitochondria contribute to reduced ROS levels.

We considered the possibility that the effect on lifespan by the mitochondrial fusion pathway was primarily due to changes in energy levels that were a secondary consequence of the changes in mitochondrial morphology. We analyzed three energy sensors that have an impact on lifespan: LET-363/TOR; SIR-2.1; and AAK-2/AMPK. LET-363/TOR responds to metabolic inputs to regulate lifespan through inhibition of the transcription factors DAF-16, SKN-1, and PHA-440, 41. SIR-2.1 is a NAD+-dependent histone deacetylase whose overexpression increases lifespan by activating DAF-16, UPRmt, and autophagy42. The AMP-activated protein kinase AAK-2 extends lifespan in response to ROS signals and impaired glycolysis, such as inactivation of GPI-1, glucose phosphate isomerase35, 43. Overexpression of SIR-2.1 or AAK-2, and RNAi depletion of let-363/TOR or gpi-1, all exhibited increased mitochondrial elongation (Figs. 8b, c and 9h, i and Supplementary Fig. 5). eat-3 RNAi reduced the extended lifespan of these animals, suggesting that the elongated mitochondrial morphology contributes to their lifespan extension (Fig. 9f–i and Supplementary Fig. 5).

The UPRmt links mitochondrial ETC dysfunction during larval stages with lifespan extension in adults44. To determine whether the IIS/SCFLIN-23-regulated mitochondrial fusion pathway activates the UPRmt, we analyzed the induction of the UPRmt reporters Phsp-6::GFP45. RNAi depletion of spg-7 is known to induce UPRmt46, and, consistently, we observed increased expression of Phsp-6::GFP in spg-7(RNAi) animals (Fig. 10a, b). Notably, ppgn-1 RNAi, which induces substantially more mitochondrial fusion than spg-7 RNAi (Figs. 1c and 3b), did not induce Phsp-6::GFP expression (Fig. 10a, b). Additionally, cand-1, lin-23, and cul-1 RNAi depletions did not induce Phsp-6::GFP, indicating that the mitochondrial fusion pathway does not induce UPRmt.

Fig. 10

The UPRmt is not involved in the mitochondrial fusion pathway. a Representative images of the UPRmt marker Phsp-6::GFP in L4/young-adult-stage animals for the indicated RNAi treatments. Scale bar, 200 µm. b Quantification of Phsp-6::GFP signal for the RNAi treatments shown in a for 20 animals. Error bars denote s.e.m. P values were determined by Student’s t-test. c, d Survival curves for atfs-1(et17) gain-of-function mutants with the indicated RNAi treatments; the wild-type survival curve is shown in both graphs for comparison. e The percentages of body-wall muscle cells with tubular, elongated, and fragmented mitochondria in the indicated genotypes and RNAi treatments. P values were determined by χ 2-test. Sample size (n) of muscle cells from left to right are: 427; 234; 333. f Quantification of Phsp-6::GFP signal for 20 animals swimming for the indicated times. Error bars denote s.e.m. P values determined by Student’s t-test. The quantification was performed as for b and the two graphs can be compared directly. No significant differences in Phsp-6::GFP were observed relative to 0 min control animals. For all panels, asterisks above bars denote P value comparisons to wild type/controls; asterisks above lines denote comparisons under the lines: *P < 0.05; **P < 0.01; ***P < 0.001; ns = not significant

The induction of UPRmt is mediated by the transcription factor ATFS-1, which is required for the expression of hsp-6 and other UPRmt-regulated genes46. Counterintuitively, a gain-of-function mutation of ATFS-1, atfs-1(et17gf) 47, with constitutively activated UPRmt, exhibits reduced lifespan, not lifespan extension48. We used the atfs-1(et17) gain-of-function mutant to ask whether activation of the mitochondrial fusion pathway reduces lifespan further, as would be expected if the pathway further activated the UPRmt. We found that RNAi depletion of cand-1, lin-23, spg-7, and ppgn-1 increased the lifespan of atfs-1(et17) mutants, suggesting that the lifespan extension operates independently of the UPRmt (Fig. 10c, d). Induction of UPRmt by loss of spg-7 is abolished upon the loss of atfs-1 46. However, we did not observe significant differences in mitochondrial morphology between spg-7(∆) mutants and spg-7(∆); atfs-1(RNAi) mutants (Fig. 10e). The UPRmt is also not induced upon swimming, unlike the mitochondrial fusion pathway (Fig. 10f). These results suggest that the increase in mitochondrial fusion associated with inactivation of the IIS/SCFLIN-23-regulated pathway occurs independently of UPRmt.


Our study has revealed a pathway by which the ubiquitin ligase SCFLIN-23 and IIS control mitochondrial fusion in C. elegans (Fig. 4a). We found that the CRL regulator CAND-1 and SCFLIN-23 are required to activate AKT-1. Active AKT-1 inhibits the nuclear localization of DAF-16, which inhibits the expression of the mitochondrial m-AAA proteases SPG-7 and PPGN-1. Decreased expression of SPG-7 and PPGN-1 is associated with increased levels of the mitochondrial fusion protein EAT-3, whose activity is essential for the increased mitochondrial fusion that is observed upon inactivating the pathway components CAND-1, LIN-23, and PPGN-1. Our analysis does not indicate whether SPG-7 and PPGN-1 directly reduce EAT-3 levels or whether the impact on EAT-3 is indirect. Given the additional functions of the yeast and mammalian orthologs of spg-7 and ppgn-1, it is likely that reducing their activity affects multiple mitochondrial pathways29. Additionally, SCF E3s are known to target multiple substrates16, 17, and we cannot rule out the possibility that CAND-1 and SCFLIN-23 have an impact on mitochondria through other pathways.

Our work identifies the SCFLIN-23-mediated activation of AKT-1 as a new regulatory mechanism for IIS, for which AKT-1 is a critical component. Currently, it is unclear how SCFLIN-23 promotes AKT-1 phosphorylation. Ubiquitylation has been linked to AKT activation in mammalian cells, wherein K63-linked poly-ubiquitylation of AKT is required for its translocation to the plasma membrane, where it is activated49, 50. In mammalian cells, the K63 linkage is only detectable with anti-K63 ubiquitin antibodies immediately after stimulation of the relevant signaling pathways, but not in unstimulated cells49, 50. We have been unable to detect K63 poly-ubiquitin on immunoprecipitated AKT-1::GFP. However, the inability to rapidly induce signaling in intact animals limits the implications of this negative result.

In mouse skeletal muscle cells, physical exercise increases mitochondrial fusion34. We have shown a similar result in C. elegans using swimming as a source of exercise. C. elegans swimming is associated with a reduction in the level of ATP, indicating that the “thrashing” swim strokes involve a greater expenditure of energy than the normal sinusoidal movement on plates. Swimming induces an increase in the level of elongated mitochondria, and this increase appears to be controlled by the IIS/SCFLIN-23-regulated pathway, as the increase in elongated mitochondria is blocked in daf-16 mutants as well as cand-1; spg-7(ek25) mutants, which are no longer responsive to DAF-16-mediated inhibition of spg-7 expression.

In rodents, modest physical exercise correlates with increases in mean lifespan and healthspan51, and we have found that exercise regimens increase C. elegans lifespan. The lifespan extension in response to exercise is not observed in daf-16 mutants or cand-1; spg-7(ek25) mutants, which are unable to activate the IIS/SCFLIN-23 pathway to increase mitochondrial fusion, suggesting that increased mitochondrial elongation positively contributes to exercise-induced longevity.

We observed an increase in elongated mitochondria in diverse longevity pathways, including: IIS inactivation; caloric restriction; germline depletion; ETC dysfunction leading to UPRmt; TOR inactivation; Sirtuin overexpression; AMPK overexpression; impaired glycolysis; and exercise. RNAi depletions of six genes that cause ETC dysfunction leading to extended lifespan were previously shown to increase mitochondrial fusion52. These observations suggest that increased levels of elongated mitochondria are broadly associated with longevity.

Notably, the extended lifespans for the longevity pathway mutants with increased mitochondrial elongation were significantly reduced by eat-3 RNAi, which reduces mitochondrial fusion. eat-3 RNAi does not affect the lifespans of wild-type animals or long-lived vhl-1 mutants, neither of which exhibit increased levels of elongated mitochondria. This suggests that inactivation of the mitochondrial fusion protein EAT-3 does not directly reduce lifespan, but rather indirectly reduces lifespan by countering the beneficial effects of elongated mitochondria. RNAi depletion of the outer membrane mitochondrial fusion protein FZO-1 also reduces daf-2 mutant-extended lifespan.

ppgn-1 mutants have a substantial increase in elongated mitochondria, yet have only modestly longer lifespans. It has been reported that blocking fission by inactivating DRP-1 reduces53 or has no effect on the lifespan of wild-type animals54, but increases the extended lifespans of IIS pathway mutants54. These observations suggest that increasing mitochondrial elongation, by itself, does not greatly extend lifespan. Rather, increased levels of elongated mitochondria appear to be a requirement for the survival of older animals in diverse longevity pathways. Thus, while increased levels of elongated mitochondria contribute to older animal survival, the precise level of the increase would not be expected to be predictive of the extent of longevity.

Elongated mitochondria have increased mitochondrial efficiency3; in addition, we have observed increased ATP levels in mitochondrial fusion pathway mutants that have increased mitochondrial elongation. This leads to the hypothesis that increased mitochondrial efficiency resulting in sufficient ATP production is required in diverse longevity pathways to allow the survival of long-lived adults.

We observed that vhl-1 mutants do not have increased levels of elongated mitochondria and their extended lifespan is not reduced by eat-3 RNAi. Interestingly, a large-scale Cas9 inactivation screen in human cells found that inactivation of VHL allowed a bypass of the complete block on mitochondrial respiration55. VHL functions as a substrate receptor for the CRL2VHL ubiquitin ligase, which degrades the hypoxia-inducible factor HIF1Α. During hypoxia, the HIF1Α transcriptional response is associated with a major reorganization of energy pathways to allow energy generation in the absence of oxidative mitochondrial metabolism55. Thus, unregulated HIF1Α transcriptional activity can functionally replace the requirement for mitochondrial respiration in human cells55.

C. elegans VHL-1 similarly targets the degradation of the HIF1Α ortholog HIF-156. HIF-1 is required for the lifespan extension of vhl-1 mutants38. If the role of HIF-1 in providing alternate energy pathways under hypoxic conditions is conserved, then vhl-1 mutants would have increased energy capacity via HIF-1-mediated induction of energy metabolism. It is possible that increased energy capacity is a requirement for survival beyond the normal lifespan, and that most longevity mutants increase energy capacity via mitochondrial elongation, while vhl-1 mutants utilize HIF-1-mediated transcriptional activity. It will be interesting to determine whether increased mitochondrial fusion and/or energy metabolism contributes to the survival and healthspan of older animals in other species.


C. elegans strains

The following C. elegans strains were used, with strain designations in parentheses: wild type Bristol (N2), wild type Hawaiian (CB4856), cand-1(tm1683) (ET327), cand-1(tm1683) outcrossed 8× into Hawaiian strain CB4856 (ET335), cand-1(tm1683); spg-7(ek25) (ET329), lin-23(e1883)/mIn-1 (ET351), daf-16(mu86) (CF1038), spg-7(ad2249) (DA2249)57, spg-7(tm2312) (ET352), daf-2(e1370) (CB1370), muEx248 [pNL209(Pdaf-16::DAF-16::GFP) + Podr-1::RFP], Pakt-1::AKT-1::GFP (SP209)58, glp-1(e2141) (CF1903), eat-6(ad467) (DA467), zcIs14 [Pmyo-3::GFP(mit)] (SJ4103)59, cand-1(tm1683); zcIS14 (ET353), cand-1(tm1683); spg-7(ek25); zcIS14 (ET354), spg-7(tm2312); zcIS14 (ET355), daf-2(e1370); zcIS14 (ET356), daf-16(mu86); zcIS14 (ET357), cand-1(tm1683); daf-16(mu86); zcIS14 (ET358), spg-7(ek25); zcIS14 (ET359) atfs-1(et17) (QC117); vhl-1(ok161) (CB5602); eat-2(ad1116) (DA1116), uthEx299 [aak-2 (genomic aa1-aa321)::GFP::unc-54 3′UTR + Pmyo-2::tdTomato] (AGD731), lin-15(n765ts); bcEx665 [Phsp::FZO-1::GFP; lin-15(+)] (MD2642), unc-119(ed3); ekEx37[pPD96.52/Pmyo-3::DRP-1::GFP; unc-119(+)] (ET537), geIs3 [sir-2.1(+) + rol-6(su1006)] (LG394), and zcIs13[Phsp-6::GFP] (SJ4100).

RNA interference

Feeding-RNAi constructs (expressed in HT115 bacteria) were obtained from the Ahringer library60. RNAi-feeding bacteria were induced in 1 mM IPTG in liquid 2xYT media plus 100 µg ml−1 carbenicillin (Gold Biotechnology) for 5–7 h with the exception of lin-23, let-363, and atfs-1 RNAi bacteria, which was induced by plating overnight cultures of the lin-23 RNAi bacteria on 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) plus 100 µg ml−1 carbenicillin plates. Double RNAi treatments were performed by combining RNAi bacteria at a 1:1 ratio (unless otherwise indicated) using OD600 optical densities to quantify the bacteria prior to seeding plates. Unless otherwise indicated, eggs were placed on the RNAi plates and adults from the next generation were analyzed.

The isolation of the ek25 cand-1 suppressor mutation

cand-1(tm1683) mutants were synchronized as L1-stage larvae by isolating eggs by hypochlorite treatment61 and allowing the eggs to hatch overnight in M9 buffer61 supplemented with 5 µg ml−1 cholesterol. The synchronized L1-stage larvae were grown on NGM plates with OP50 bacteria until the L4/young-adult stage, when they were mutagenized with 0.5 mM N-nitroso-N-ethylurea (ENU)62 for 4 h. The mutagenized animals were cultured on NGM plates with OP50 for 1 day, at which time F1 mutant eggs were isolated from the gravid adults and synchronized as L1 larvae. The F1 mutant animals were cultured on NGM plates with OP50 bacteria until they became gravid adults. F2 mutant eggs were isolated from the F1 gravid adults and synchronized as L1 larvae. In all, 10,000 F2 mutant L1 larvae were grown in a 500 ml liquid culture61 supplemented with OP50 bacteria for 11 days, and then collected by centrifugation and regrown in fresh liquid culture for 3 days. Propagation in liquid culture is a hardship for C. elegans, and this culturing condition selects for healthier cand-1 suppressors, as cand-1(tm1683) mutants have lower brood sizes, impenetrant embryonic lethality, and impenetrant larval arrest21. Animals from the liquid culture were placed on 3xNGM plates. Twelve healthy L4 larvae that did not exhibit cand-1 mutant phenotypes (e.g., no bobtail phenotype) were cloned onto separate NGM plates with OP50 bacteria. One of these cloned animals (cand-1(tm1683); ek25) had 100% healthy progeny without visible cand-1 mutant phenotypes.

SNP mapping

The cand-1(tm1683); ek25 strain was outcrossed 10 times into the Hawaiianized cand-1(tm1683) strain ET335. The resulting Hawaiianized cand-1; ek25 strain appears to be largely Hawaiian throughout the genome with the exception of the +7.5 to +11.5 region of chromosome V, which contains the cand-1 gene and remains N2 Bristol. cand-1(tm1683) was crossed with the Hawaiianized cand-1(tm1683); ek25, and confirmed F1s were allowed to lay eggs. In all, 273 L1 larvae from the F2 generation were transferred onto separate csn-3 RNAi plates. cand-1 mutants subjected to csn-3 RNAi have an enhanced phenotype of 100% arrested embryos; in contrast, cand-1; ek25 is highly resistant to csn-3 RNAi (Supplementary Table S1). Using the resistance to csn-3 RNAi as a measure of cand-1 suppression, we identified 40 “suppressed” and 40 “non-suppressed” plates from the 273 F2 cross progeny. We performed whole-genome SNP mapping using previously described sets of primers63. Pooled DNA from the suppressed and non-suppressed progeny were used to generate PCR amplicons that were digested with the Dra I restriction enzyme (as the SNPs differed in the presence or absence of a Dra I site) in order to distinguish Hawaiian from N2 Bristol genomic DNA. We observed an enrichment of Hawaiian regions in the Chromosome I region −4 to −2 in the “suppressed” population (Supplementary Fig. 1a). We then looked at the distribution of Hawaiian vs. N2 regions in the each of the 40 “suppressed” clones (Supplementary Fig. 1b). Most clones were Hawaiian in the −4 to −2 chromosome I region, but 12 clones were heterozygous in parts of this region. The only SNP that was Hawaiian in all clones was −3.18, which narrowed the location of the suppressor to the −3.96 to −2.07 interval. By sequencing SNPs in this region, we narrowed the region containing the suppressor to −3.48 to −3.18 and found a 26 bp insertion mutation in the major intron of spg-7 (located at −3.22 on chromosome I). The insertion mutation segregated completely with the rescue of the cand-1(tm1683) mutant phenotypes through additional outcrossings, suggesting that it is the cand-1 suppressor mutation.

DAF-16 and PQM-1 data meta-analysis

DAF-16 has been found to predominantly function as a transcriptional activator via binding regulatory regions through DBE sites64. In contrast, genes that are repressed in a DAF-16-dependent manner are predominantly repressed by the PQM-1 transcription factor via binding to DAE sites25. However, an analysis of DAF-16-reponsive genes shows that, of 2196 genes repressed in a DAF-16-dependent manner at p < 0.01 significance, 563 (26%) were shown to be bound by DAF-16 but not by PQM-1, and 131 of the genes have position-specific affinity matrices affinity scores of 0 for DAE sites but positive scores for DBE sites25. This suggests that DAF-16 can repress gene expression independently of PQM-1. The activating spg-7(ek25) mutation disrupts a DBE site, and both spg-7 and ppgn-1 regulatory regions have been found to be bound by DAF-16 but not by PQM-125. This suggests that spg-7 and ppgn-1 are repressed by DAF-16 in a PQM-1-independent manner.

Real-time quantitative RT-PCR

Total RNA was isolated from whole-animal lysate using TRIzol reagent (Life Technologies) according to the manufacturer’s instructions. RNA was reverse-transcribed into cDNA using the SuperScript III First-Strand Synthesis for RT-PCR kit from Life Technologies, according to the manufacturer’s instructions. The first-strand cDNA was used for PCR amplification of spg-7 and ppgn-1. rpl-19, which encodes the large ribosomal subunit L-19, was used as a normalization control. Reverse transcriptase polymerase chain reaction (RT-PCR) was performed using SYBR Green Supermix (Bio-Rad) and analyzed using the CFX Connect Real-Time PCR Detection System (Bio-Rad). The primers used were: spg-7, forward: 5ʹ-CCGTTGTCGTTTGAGACACC-3ʹ, reverse: 5ʹ-CGGCGAAGTGCGTTCATTAC-3ʹ; ppgn-1, forward: 5ʹ-ATGCTTCTACACCGCTCCAC-3ʹ, reverse: 5ʹ-GTGGAAATCTGCGAGCACT-3ʹ; eat-3, forward: 5ʹ-AGAGCATCGAAACCGGATGG-3ʹ, reverse: 5ʹ-GCGTCAGCATAGCTTCTTCG-3ʹ; and rpl-19, forward: 5ʹ-CGCGCAAAGGGAAACAACTT-3ʹ, reverse: 5ʹ-CTTGCGGCTCTCCTTGTTCT-3ʹ. mRNA levels were normalized using rpl-19 mRNA and the relative fold change was calculated using the ∆∆Ct method. The normalized mRNA levels are reported in arbitrary units with the wild-type level set to 1.0.

Epifluorescence microscopy

RNAi-treated and mutant animals were maintained at 20 °C, and L4-stage animals to young-adult-stage animals were used for imaging. FZO-1::GFP expressing L4-stage animals were subjected to heat-shock treatment at 33.5 °C for 10 h to ensure stable expression prior to imaging. Animals were mounted on slides with 0.5 mM levamisole (Sigma) to induce muscle paralysis. Animals were visualized with a Zeiss Axioskop microscope, and images were taken with a Hamamatsu ORCA-ER digital camera using Openlab 4.0.2 software (Agilent Technologies). Images were processed and analyzed with Adobe Photoshop CS6 or CC software. Matched images were taken with the same exposure and were processed and analyzed identically. Images from 20 animals were analyzed for AKT::GFP (Supplementary Fig. 6b), FZO-1::GFP (Supplementary Fig. 7a), DRP-1::GFP (Supplementary Fig. 7b), and mitochondrial GFP (Supplementary Fig. 7c) levels.

Western blot analysis

Mixed-stage animals were lysed in SDS sample buffer and used for western blot analysis. The following mouse primary antibodies were used: anti-GFP (GF28R, Thermo Scientific, cat. no. MA5-15256; 1:2000) and anti-α-tubulin (DM1A, Sigma, cat. no. T9026; 1:4000). The following rabbit primary antibodies were used: anti-EAT-3 (1:1000)5; anti-AKT phospho-substrate (Cell Signaling, cat. no. 9611 S; 1:1000); and anti-histone H4 (Upstate Biotechnology, cat. no. 07-108; 1:1000). Anti-rabbit-HRP (ThermoFisher Scientific, cat. no. 32460; 1:5000) and anti-mouse-HRP (ThermoFisher Scientific, cat. no. 32430; 1:10,000) were used as secondary antibodies. Chemiluminescence was performed with the Advanced ECL chemiluminescence system (GE Healthcare). Western Blot images were obtained using the Bio-Rad ChemiDoc MP Imaging System. Western blots were analyzed and quantified with Adobe Photoshop CS6 or CC software using non-saturated images with background-level subtracted. Signals of the bands of interest were normalized with α-tubulin or histone H4, and are reported in arbitrary units. Images of the uncropped western blots for Fig. 2c, d, f are shown in Supplementary Fig. 14.

The expected molecular weight of EAT-3 isoforms was determined as follows. The mitochondrial targeting sequence (MTS), which is cleaved from the precursor protein to form the L-isoform, was identified using the MitoProt program65. The predicted MTS in EAT-3 (NP495986) encompasses residues 1–59. The predicted L-isoform therefore encompasses amino acids 60–964 of EAT-3. The mammalian S2 cleavage site has been identified between amino acids 217–223 of human OPA1 (NP_570849)66. The human S2 cleavage site corresponds to residues 215–221 in EAT-3, cleavage of which would produce an S-isoform of between 216–964 and 222–964 amino acids.

Lifespan analysis

Survival assays67 were performed at 20 °C. Eggs were isolated from gravid adults by hypochlorite treatment and allowed to hatch on RNAi-feeding bacteria plates, with the exception of cand-1, cul-1, lin-23, clk-1, and let-363 RNAi, where wild-type hermaphrodites were transferred to RNAi-feeding bacteria plates as late-L4-stage larvae to ensure that prior larval development was normal. Animals were transferred to fresh plates every alternate day throughout the lifespan study. For all lifespan studies, animals in the L4 larval stage were picked on day 0. Lifespan analysis of wild-type adult hermaphrodites subjected to a swimming regimen was performed by adding 3 ml of M9 buffer to plates, and the plates were placed on a rocking platform at room temperature to prevent the animals from settling down. The daily swim regimens are described in the main text. After swimming, animals were transferred to fresh agar plates with OP50 bacteria. The non-swim control animals were placed at room temperature for the duration of the swim period, and also transferred to new OP50-seeded NGM plates at the same time as swim animals. Animals that crawled off the plate or had ruptured vulvae were censored. Immobile adults were counted as dead when they failed to respond to prodding. P values were calculated by the Log-rank (Mantel–Cox) and Wilcoxon tests using GraphPad Prism software (version 6.0).

ATP quantification

ATP levels were measured using the EnzyLightTM ADP/ATP Ratio Assay Kit (ELDT-100) from BioAssay Systems as per the manufacturer’s protocol with the following modifications. Eggs were isolated from gravid adults by hypochlorite treatment and allowed to hatch on RNAi-feeding bacteria plates, or OP50 plates for mutant animals, and maintained at 20 °C. L4-stage animals were collected by centrifugation and washed three times in M9 buffer +5 mg ml−1 cholesterol, flash-frozen in liquid nitrogen, and stored at −80 °C. Frozen samples were boiled for 15 min to release ATP, and centrifuged at 15,000 × g to pellet debris. The supernatant was diluted twofold in RNase/DNase-free water, and used for ATP measurement. Protein concentration was measured using the Bradford reagent (Sigma). ATP levels were normalized to protein concentration.

Analysis of mitochondrial morphology

Adult hermaphrodites expressing mitochondrial matrix-targeted GFP [Pmyo-3::GFP(mit)] in their body-wall muscle cells59 were imaged for mitochondrial morphology. Cells were categorized as harboring tubular, elongated, or fragmented mitochondria, as described5. Mitochondrial morphology was assessed with at least 100 muscle cells analyzed for each condition, and was scored blinded where noted. To quantitatively categorize cells harboring tubular, elongated, or fragmented mitochondria, the two-dimensional areas of mitochondria were measured as previously described68. The areas (in pixels) of the five largest mitochondria per cell in ~40 body-wall muscle cells were measured from micrographs using Photoshop software (Adobe).

Analysis of mitochondrial ROS

Eggs were placed on RNAi plates and L4-stage larvae were used for the analysis of mitochondrial ROS with the dye MitoSOX Red (Life Technologies), which was performed as previously described39. Animals were incubated in 10 µM MitoSOX Red in M9 buffer with cholesterol and RNAi bacteria in the dark at 20 °C for 24 h. Animals were washed two times in M9 buffer and incubated in M9 buffer with OP50 bacteria for an hour to clear their intestines of residual dye. ROS levels were analyzed in the posterior pharyngeal bulb by measuring the MitoSOX Red epifluorescence intensity with a 300 ms exposure. Epifluorescence was analyzed with optical filters of 470/40 excitation wavelength and 500 long-pass emission wavelength. Mitochondrial ROS levels were measured in adult hermaphrodites 1 day-post-L4 stage.

Physical exertion swimming assay

L4-stage larvae and young adults expressing the Pmyo-3::GFP(mit) transgene were placed on one 6-cm OP50-seeded NGM plate per time point. To induce the swimming behavior, 3 ml of M9 buffer was added to each plate, and the plates were placed on a rocking platform to prevent the animals from settling down. At each time point, animals were collected by centrifugation, and visualized by epifluorescence microscopy to determine mitochondrial morphology (obtaining data from at least 100 cells). To determine the swim rate, 12 animals were analyzed for the number of swim strokes per minute for each genotype.

Data availability

The authors declare that all data supporting the findings of this study are available within this article, its Supplementary Information files, or are available from the corresponding author upon reasonable request.


  1. 1.

    Chan, D. C. Fusion and fission: interlinked processes critical for mitochondrial health. Annu. Rev. Genet. 46, 265–287 (2012).

  2. 2.

    Gomes, L. C. & Scorrano, L. Mitochondrial morphology in mitophagy and macroautophagy. Biochim. Biophys. Acta 1833, 205–212 (2013).

  3. 3.

    Liesa, M. & Shirihai, O. S. Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. Cell Metab. 17, 491–506 (2013).

  4. 4.

    Zhao, J., Lendahl, U. & Nister, M. Regulation of mitochondrial dynamics: convergences and divergences between yeast and vertebrates. Cell. Mol. Life Sci. 70, 951–976 (2013).

  5. 5.

    Kanazawa, T. et al. The C. elegans Opa1 homologue EAT-3 is essential for resistance to free radicals. PLoS Genet. 4, e1000022 (2008).

  6. 6.

    Rolland, S. G., Lu, Y., David, C. N. & Conradt, B. The BCL-2-like protein CED-9 of C. elegans promotes FZO-1/Mfn1,2- and EAT-3/Opa1-dependent mitochondrial fusion. J. Cell Biol. 186, 525–540 (2009).

  7. 7.

    Rojo, M., Legros, F., Chateau, D. & Lombes, A. Membrane topology and mitochondrial targeting of mitofusins, ubiquitous mammalian homologs of the transmembrane GTPase Fzo. J. Cell Sci. 115, 1663–1674 (2002).

  8. 8.

    Bach, D. et al. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J. Biol. Chem. 278, 17190–17197 (2003).

  9. 9.

    Santel, A. et al. Mitofusin-1 protein is a generally expressed mediator of mitochondrial fusion in mammalian cells. J. Cell Sci. 116, 2763–2774 (2003).

  10. 10.

    Shen, T. et al. Mitofusin-2 is a major determinant of oxidative stress-mediated heart muscle cell apoptosis. J. Biol. Chem. 282, 23354–23361 (2007).

  11. 11.

    Liu, X., Weaver, D., Shirihai, O. & Hajnoczky, G. Mitochondrial ‘kiss-and-run’: interplay between mitochondrial motility and fusion-fission dynamics. EMBO J. 28, 3074–3089 (2009).

  12. 12.

    Bratic, A. & Larsson, N. G. The role of mitochondria in aging. J. Clin. Invest. 123, 951–957 (2013).

  13. 13.

    Yanos, M. E., Bennett, C. F. & Kaeberlein, M. Genome-wide RNAi longevity screens in Caenorhabditis elegans. Curr. Genomics 13, 508–518 (2012).

  14. 14.

    Tatar, M. & Sedivy, J. M. Mitochondria: masters of epigenetics. Cell 165, 1052–1054 (2016).

  15. 15.

    Murphy, C. T. & Hu, P. J. in WormBook (ed. The C. elegans Research Community) (2013).

  16. 16.

    Bosu, D. R. & Kipreos, E. T. Cullin-RING ubiquitin ligases: global regulation and activation cycles. Cell Div. 3, 7 (2008).

  17. 17.

    Lydeard, J. R., Schulman, B. A. & Harper, J. W. Building and remodelling Cullin-RING E3 ubiquitin ligases. EMBO Rep. 14, 1050–1061 (2013).

  18. 18.

    Zemla, A. et al. CSN- and CAND1-dependent remodelling of the budding yeast SCF complex. Nat. Commun. 4, 1641 (2013).

  19. 19.

    Pierce, N. W. et al. Cand1 promotes assembly of new SCF complexes through dynamic exchange of F box proteins. Cell 153, 206–215 (2013).

  20. 20.

    Wu, S. et al. CAND1 controls in vivo dynamics of the cullin 1-RING ubiquitin ligase repertoire. Nat. Commun. 4, 1642 (2013).

  21. 21.

    Bosu, D. R. et al. C. elegans CAND-1 regulates cullin neddylation, cell proliferation and morphogenesis in specific tissues. Dev. Biol. 346, 113–126 (2010).

  22. 22.

    Juhola, M. K., Shah, Z. H., Grivell, L. A. & Jacobs, H. T. The mitochondrial inner membrane AAA metalloprotease family in metazoans. FEBS Lett. 481, 91–95 (2000).

  23. 23.

    Labrousse, A. M., Zappaterra, M. D., Rube, D. A. & van der Bliek, A. M. C. elegans dynamin-related protein DRP-1 controls severing of the mitochondrial outer membrane. Mol. Cell 4, 815–826 (1999).

  24. 24.

    Koppen, M., Metodiev, M. D., Casari, G., Rugarli, E. I. & Langer, T. Variable and tissue-specific subunit composition of mitochondrial m-AAA protease complexes linked to hereditary spastic paraplegia. Mol. Cell Biol. 27, 758–767 (2007).

  25. 25.

    Tepper, R. G. et al. PQM-1 complements DAF-16 as a key transcriptional regulator of DAF-2-mediated development and longevity. Cell 154, 676–690 (2013).

  26. 26.

    Gerstein, M. B. et al. Integrative analysis of the Caenorhabditis elegans genome by the modENCODE project. Science 330, 1775–1787 (2010).

  27. 27.

    Lin, K., Hsin, H., Libina, N. & Kenyon, C. Regulation of the Caenorhabditis elegans longevity protein DAF-16 by insulin/IGF-1 and germline signaling. Nat. Genet. 28, 139–145 (2001).

  28. 28.

    Yung, H. W., Charnock-Jones, D. S. & Burton, G. J. Regulation of AKT phosphorylation at Ser473 and Thr308 by endoplasmic reticulum stress modulates substrate specificity in a severity dependent manner. PLoS ONE 6, e17894 (2011).

  29. 29.

    Anand, R., Langer, T. & Baker, M. J. Proteolytic control of mitochondrial function and morphogenesis. Biochim. Biophys. Acta 1833, 195–204 (2013).

  30. 30.

    Escobar-Henriques, M. & Anton, F. Mechanistic perspective of mitochondrial fusion: tubulation vs. fragmentation. Biochim. Biophys. Acta 1833, 162–175 (2013).

  31. 31.

    Ishihara, N., Fujita, Y., Oka, T. & Mihara, K. Regulation of mitochondrial morphology through proteolytic cleavage of OPA1. EMBO J. 25, 2966–2977 (2006).

  32. 32.

    Duvezin-Caubet, S. et al. OPA1 processing reconstituted in yeast depends on the subunit composition of the m-AAA protease in mitochondria. Mol. Biol. Cell 18, 3582–3590 (2007).

  33. 33.

    Palikaras, K., Lionaki, E. & Tavernarakis, N. Coordination of mitophagy and mitochondrial biogenesis during ageing in C. elegans. Nature 521, 525–528 (2015).

  34. 34.

    Picard, M. et al. Acute exercise remodels mitochondrial membrane interactions in mouse skeletal muscle. J. Appl. Physiol. 115, 1562–1571 (2013).

  35. 35.

    Zarse, K. et al. Impaired insulin/IGF1 signaling extends life span by promoting mitochondrial L-proline catabolism to induce a transient ROS signal. Cell Metab. 15, 451–465 (2012).

  36. 36.

    Lakowski, B. & Hekimi, S. The genetics of caloric restriction in Caenorhabditis elegans. Proc. Natl Acad. Sci. USA 95, 13091–13096 (1998).

  37. 37.

    Berman, J. R. & Kenyon, C. Germ-cell loss extends C. elegans life span through regulation of DAF-16 by kri-1 and lipophilic-hormone signaling. Cell 124, 1055–1068 (2006).

  38. 38.

    Mehta, R. et al. Proteasomal regulation of the hypoxic response modulates aging in C. elegans. Science 324, 1196–1198 (2009).

  39. 39.

    Dingley, S. et al. Mitochondrial respiratory chain dysfunction variably increases oxidant stress in Caenorhabditis elegans. Mitochondrion 10, 125–136 (2010).

  40. 40.

    Robida-Stubbs, S. et al. TOR signaling and rapamycin influence longevity by regulating SKN-1/Nrf and DAF-16/FoxO. Cell Metab. 15, 713–724 (2012).

  41. 41.

    Sheaffer, K. L., Updike, D. L. & Mango, S. E. The Target of Rapamycin pathway antagonizes pha-4/FoxA to control development and aging. Curr. Biol. 18, 1355–1364 (2008).

  42. 42.

    Mouchiroud, L. et al. The NAD(+)/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell 154, 430–441 (2013).

  43. 43.

    Schulz, T. J. et al. Glucose restriction extends Caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress. Cell Metab. 6, 280–293 (2007).

  44. 44.

    Dillin, A. et al. Rates of behavior and aging specified by mitochondrial function during development. Science 298, 2398–2401 (2002).

  45. 45.

    Haynes, C. M. & Ron, D. The mitochondrial UPR - protecting organelle protein homeostasis. J. Cell Sci. 123, 3849–3855 (2010).

  46. 46.

    Nargund, A. M., Pellegrino, M. W., Fiorese, C. J., Baker, B. M. & Haynes, C. M. Mitochondrial import efficiency of ATFS-1 regulates mitochondrial UPR activation. Science 337, 587–590 (2012).

  47. 47.

    Rauthan, M., Ranji, P., Aguilera Pradenas, N., Pitot, C. & Pilon, M. The mitochondrial unfolded protein response activator ATFS-1 protects cells from inhibition of the mevalonate pathway. Proc. Natl Acad. Sci. USA 110, 5981–5986 (2013).

  48. 48.

    Bennett, C. F. et al. Activation of the mitochondrial unfolded protein response does not predict longevity in Caenorhabditis elegans. Nat. Commun. 5, 3483 (2014).

  49. 49.

    Yang, W. L. et al. The E3 ligase TRAF6 regulates Akt ubiquitination and activation. Science 325, 1134–1138 (2009).

  50. 50.

    Chan, C. H. et al. The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis. Cell 149, 1098–1111 (2012).

  51. 51.

    Mercken, E. M., Carboneau, B. A., Krzysik-Walker, S. M. & de Cabo, R. Of mice and men: the benefits of caloric restriction, exercise, and mimetics. Ageing Res. Rev. 11, 390–398 (2012).

  52. 52.

    Lee, S. S. et al. A systematic RNAi screen identifies a critical role for mitochondria in C. elegans longevity. Nat. Genet. 33, 40–48 (2003).

  53. 53.

    Kim, H. et al. Fine-tuning of Drp1/Fis1 availability by AKAP121/Siah2 regulates mitochondrial adaptation to hypoxia. Mol. Cell 44, 532–544 (2011).

  54. 54.

    Yang, C. C., Chen, D., Lee, S. S. & Walter, L. The dynamin-related protein DRP-1 and the insulin signaling pathway cooperate to modulate Caenorhabditis elegans longevity. Aging. Cell. 10, 724–728 (2011).

  55. 55.

    Jain, I. H. et al. Hypoxia as a therapy for mitochondrial disease. Science 352, 54–61 (2016).

  56. 56.

    Epstein, A. C. et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43–54 (2001).

  57. 57.

    Zubovych, I. O., Straud, S. & Roth, M. G. Mitochondrial dysfunction confers resistance to multiple drugs in Caenorhabditis elegans. Mol. Biol. Cell 21, 956–969 (2010).

  58. 58.

    Padmanabhan, S. et al. A PP2A regulatory subunit regulates C. elegans insulin/IGF-1 signaling by modulating AKT-1 phosphorylation. Cell 136, 939–951 (2009).

  59. 59.

    Benedetti, C., Haynes, C. M., Yang, Y., Harding, H. P. & Ron, D. Ubiquitin-like protein 5 positively regulates chaperone gene expression in the mitochondrial unfolded protein response. Genetics 174, 229–239 (2006).

  60. 60.

    Kamath, R. S. et al. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature. 421, 231–237 (2003).

  61. 61.

    Sulston, J. & Hodgkin, J. in The Nematode Caenorhabditis Elegans (ed W. B. Wood) 587–606 (Cold Spring Harbor Laboratory, 1988).

  62. 62.

    De Stasio, E. A. & Dorman, S. Optimization of ENU mutagenesis of Caenorhabditis elegans. Mutat. Res. 495, 81–88 (2001).

  63. 63.

    Davis, M. W. et al. Rapid single nucleotide polymorphism mapping in C. elegans. BMC Genomics 6, 118 (2005).

  64. 64.

    Schuster, E. et al. DamID in C. elegans reveals longevity-associated targets of DAF-16/FoxO. Mol. Syst. Biol. 6, 399 (2010).

  65. 65.

    Claros, M. G. & Vincens, P. Computational method to predict mitochondrially imported proteins and their targeting sequences. Eur. J. Biochem. 241, 779–786 (1996).

  66. 66.

    Alavi, M. V. & Fuhrmann, N. Dominant optic atrophy, OPA1, and mitochondrial quality control: understanding mitochondrial network dynamics. Mol. Neurodegener. 8, 32 (2013).

  67. 67.

    Kenyon, C., Chang, J., Gensch, E., Rudner, A. & Tabtiang, R. A. C. elegans mutant that lives twice as long as wild type. Nature 366, 461–464 (1993).

  68. 68.

    Westrate, L. M., Drocco, J. A., Martin, K. R., Hlavacek, W. S. & MacKeigan, J. P. Mitochondrial morphological features are associated with fission and fusion events. PLoS ONE 9, e95265 (2014).

Download references


We thank K.R. Williams, Y. Cao, Z.M. Detwiler, and F.Z.A. Nawaz for technical help; E.V. Stabb for use of equipment; H.A. Tissenbaum, A.M. van der Bliek, B. Conradt, and G.M. Benian for reagents; J. Gaertig for suggestions; and Z.M. Detwiler and members of the Kipreos lab for critical comments on the manuscript. Some C. elegans strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). This work was supported by a grant to ETK from NIH/NIGMS (R01GM074212).

Author information

S.N.C. and E.T.K. designed the study, performed the experiments, analyzed the results, and wrote the manuscript.

Correspondence to Edward T. Kipreos.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Additional information

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Chaudhari, S.N., Kipreos, E.T. Increased mitochondrial fusion allows the survival of older animals in diverse C. elegans longevity pathways. Nat Commun 8, 182 (2017).

Download citation

Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.